Early gastric cancer
Authors:
Ladislav Douda; Jiří Cyrany; Ilja Tachecí
Authors place of work:
2. interní gastroenterologická klinika Fakultní nemocnice Hradec Králové, Lékařská fakulta UK v Hradci Králové
Published in the journal:
Vnitř Lék 2022; 68(6): 371-375
Category:
Hlavní téma
doi:
https://doi.org/10.36290/vnl.2022.077
Summary
Early gastric cancer is defined histopathologically as a tumour with limited local progression to the mucosa and submucosa. The concept of early cancer was developed in the 1960s in Japan and is now widely accepted. The term of early gastric cancer included cases with/without metastatic lymph node involvement. However, a common characteristic is a favourable prognosis of the disease. The task of the endoscopist is primarily to diagnose (identify) the tumour (precancerous lesions) and to verify it by biopsy. Successful identification must be followed by its correct classification, leading to the choice of an adequate approach, which includes surveillance, endoscopic treatment (resection) or surgical treatment (with or without chemotherapy). The method of treatment is determined primarily by the nature or risk of lymph node involvement.
Keywords:
Gastric cancer – gastroscopy – early cancer – endoscopic resection
Zdroje
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249.
2. Krejčí D, Pehalová L, Talábová A, Pokorová K, Katinová I, Mužík J, Dušek L. (2018). Současné epidemiologické trendy novotvarů v České republice [online]. Ústav zdravotnických informací a statistiky České republiky. Dostupné z: http://www.uzis.cz [cit. 30. 5. 2022].
3. Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, Tsujitani S, Ono H, Tanabe S, Fukagawa T, Nunobe S, Kakeji Y, Nashimoto A. Registration Committee of the Japanese Gastric Cancer Association. Five‑year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007). Gastric Cancer. 2018 Jan;21(1):144-154.
4. Menon S, Trudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta‑analysis. Endosc Int Open. 2014 Jun;2(2):E46-50.
5. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. November 30 to December 1, 2002. Gastrointest Endosc. 2003 Dec;58(6 Suppl):S3-43.
6. Gastroent Hepatol 2022; 76(3):1-22.
7. Pimenta‑Melo AR, Monteiro‑Soares M, Libânio D, Dinis‑Ribeiro M. Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta‑analysis. Eur J Gastroenterol Hepatol. 2016 Sep;28(9):1041-9.
8. Pimentel‑Nunes P, Libânio D, Marcos‑Pinto R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F, Matysiak‑Budnik T, Annibale B, Dumonceau JM, Barros R, Fléjou JF, Carneiro F, van Hooft JE, Kuipers EJ, Dinis‑Ribeiro M. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019 Apr;51(4):365-388.
9. Dixon MF. Gastrointestinal epithelial neoplasia: Vienna revisited. Gut. 2002 Jul;51(1):130-1.
10. Association Japanese Gastric Cancer. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113-23.
11. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021 Jan;24(1):1-21.
12. Abe Y, Inamori M, Iida H, et al. Clinical characteristics of patients with gastric perforation
13. following endoscopic submucosal resection for gastric cancer. Hepatogastroenterology 2009; 56: 921-924.
14. Imagawa A, Okada H, Kawahara Y, et al. Endoscopic submucosal dissection for early
15. Gastric cancer: results and degrees of technical difficulty as well as success. Endoscopy 2006; 38: 987-990.
Štítky
Diabetologie Endokrinologie Interní lékařstvíČlánek vyšel v časopise
Vnitřní lékařství
2022 Číslo 6
- Není statin jako statin aneb praktický přehled rozdílů jednotlivých molekul
- Testování hladin NT-proBNP v časné diagnostice srdečního selhání – guidelines ESC
- Pregabalin je účinné léčivo s příznivým bezpečnostním profilem pro pacienty s neuropatickou bolestí
- Syndrom Noonanové: etiologie, diagnostika a terapie
- Moje zkušenosti s Magnosolvem podávaným pacientům jako profylaxe migrény a u pacientů s diagnostikovanou spazmofilní tetanií i při normomagnezémii - MUDr. Dana Pecharová, neurolog
Nejčtenější v tomto čísle
- Časný karcinom žaludku
- Současné trendy v diagnostice karcinomu pankreatu
- Komplexní přístup k pacientovi s arteriální hypertenzí a dyslipidemií
- SGLT-2 inhibice užitečným nástrojem v léčbě srdečního selhání se sníženou i zachovalou ejekční frakcí